{"news_desk": "National", "print_page": "13", "section_name": "Science", "subsection_name": null, "byline": {"contributor": "Katie Thomas contributed reporting from New York.\u00a0", "original": "By SABRINA TAVERNISE", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}]}, "abstract": "Generic drug makers challenge Food and Drug Admin's plan that would require them to take initiative to update their labels whenever health risks are discovered, shift that would expose them to legal liability.", "type_of_material": "News", "word_count": "794", "lead_paragraph": "The generics industry has proposed that the federal agency take full responsibility for altering labels whenever health risks are discovered rather than expecting companies to take the initiative.", "pub_date": "2015-03-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Makers of Generic Drugs Challenge F.D.A. Plan for Updated Warnings", "print_headline": "Makers of Generic Drugs Challenge F.D.A. Plan for Updated Warnings"}, "snippet": "The generics industry has proposed that the federal agency take full responsibility for altering labels whenever health risks are discovered rather than expecting companies to take the initiative.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/03/28/science/makers-of-generic-drugs-challenge-fda-plan-for-updated-warnings.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Labeling and Labels (Product)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "5515fe9438f0d84d44f0dea1", "source": "The New York Times"}